|

Probiotics combined with neoadjuvant chemoimmunotherapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Zhujiang Hospital1

Indications

  • AJCC is Classified as IB-IIIC1
  • Overall Lung Function is Adequate for the Planned Lung Resection1
  • A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection1
  • NSCLC Diagnosed by Histology or Cytology1
  • Lung Cancer1

Other1 trial

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.